
GC73947
CEP-11981
Also known as 19-methyl-3-(2-methylpropyl)-7-(pyrimidin-2-ylamino)-3,13,19,20-tetrazahexacyclo[14.7.0.02,10.04,9.011,15.017,21]tricosa-1(16),2(10),4(9),5,7,11(15),17,20-octaen-14-one
CEP-11981(ESK981; BOL 303213X) is an orally active tyrosine kinase inhibitor (TKI), which can target TIE2, VEGFR1-3 and FGFR1, and has potential anti-tumor and anti-angiogenic effects
ChemicalCAS856691-93-5MW477.56FormulaC28H27N7O
- CAS number
- 856691-93-5
- Molecular weight
- 477.56
- Formula
- C28H27N7O
- InChIKey
- AEULIVPVIDOLIN-UHFFFAOYSA-N
- Catalogue number
- GC73947
- Brand
- GLPBIO
Computed properties PubChem CID 11751922 · XLogP 3.9 · TPSA 89.7 Ų · H-bond donors 2
- XLogP
- 3.9
- TPSA
- 89.7 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 4
- Heavy atoms
- 36
SMILES CC(C)CN1C2=C(C=C(C=C2)NC3=NC=CC=N3)C4=C1C5=C(C6=CN(N=C6CC5)C)C7=C4CNC7=O
Computed descriptors from PubChem (CID 11751922), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il